SCHEMBL6808623

SCHEMBL6808623

COC(=O)C(Cc1c[nH]c(=O)nc1NC(=O)c1c(Cl)cccc1Cl)NC(=O)N1CCN(C(=O)c2c(Cl)cccc2Cl)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
POLB P06746 1/20 0.40
GFER P55789 1/20 0.40
GAA P10253 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ITGB1 P05556 4/20 0.35
ITGA4 P13612 4/20 0.35
MAPK10 P53779 2/20 0.35
MAPK8 P45983 1/20 0.35
ITGB2 P05107 1/20 0.35
ICAM1 P05362 1/20 0.35
ITGAL P20701 1/20 0.35
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6807751 0.93 CYP3A4 (0.40) CYP3A4CYP2D6CYP2C9CYP2C19POLB
SCHEMBL6807406 0.91 ITGB2 (0.41) POLBITGB1ITGA4ITGB2ICAM1
SCHEMBL6807946 0.88 GAA (0.44) CYP3A4CYP2D6CYP2C9CYP2C19POLB
SCHEMBL6808040 0.88 GAA (0.40) CYP3A4CYP2D6CYP2C9CYP2C19POLB
SCHEMBL6808154 0.86 TACR1 (0.40) CYP3A4CYP2D6CYP2C9CYP2C19POLB
SCHEMBL6807625 0.86 MEN1 (0.47) CYP3A4CYP2D6CYP2C9CYP2C19POLB
SCHEMBL6807454 0.86 GAA (0.42) CYP3A4CYP2D6CYP2C9CYP2C19POLB
SCHEMBL6807374 0.85 CYP3A4 (0.38) CYP3A4CYP2D6CYP2C9CYP2C19POLB
SCHEMBL6801497 0.85 ITGB2 (0.43) ITGB1ITGA4ITGB2ICAM1ITGAL
SCHEMBL6807436 0.84 CCR2 (0.46) POLBKDM4EITGB2ICAM1ITGAL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040039040-A1 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient TORAY INDUSTRIES, INC. (JP) 2004-02-26 US disclosed
EP-1323709-A1 UREA DERIVATIVE AND ADHESIVE-MOLECULE INHIBITOR CONTAINING THE SAME AS ACTIVE INGREDIENT TORAY INDUSTRIES, INC. (JP) 2003-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040039040-A1 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient ICAM1, VCAM1, EPCAM CYP3A4 3783/4885CYP2D6 4452/4885CYP2C9 2757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.